Patterns and Trends in Mortality Associated With and Due to Diabetes Mellitus in a Transitioning Region With 3.17 Million People: Observational Study

Overview

Journal JMIR Public Health Surveill

Publisher JMIR Publications

Date 2023 Sep 4

PMID 37665630

Authors

Xiaopan Li

Ru Liu

Yichen Chen

Yan Han

Qizhe Wang

Yaxin Xu

Jing Zhou

Sunfang Jiang

Affiliations

Soon will be listed here.

Abstract

Background: Diabetes mellitus (DM) imposes a significant disease burden in economically transitioning regions. Most transitioning regions share similar experience in urbanization processes. Shanghai's Pudong district serves as a representative area of such regions.

Objective: We aimed to assess the burden of and trends in DM mortality in Shanghai's Pudong district and analyze the impact of aging and multimorbidity.

Methods: A longitudinal, population-based study was conducted to analyze DM mortality in Pudong from 2005 to 2020. We used joinpoint regression to analyze epidemiological features and long-term trends in crude mortality rate (CMR), age-standardized mortality rate worldwide (ASMRW), and years of life lost (YLL). Furthermore, the decomposition method was used to evaluate the contribution of demographic and nondemographic factors associated with mortality.

Results: There were 49,414 deaths among individuals with DM, including 15,512 deaths due to DM. The CMR and ASMRW were 109.55/10 and 38.01/10 person-years, respectively. Among the mortality associated with and due to DM, the total annual ASMRW increased by 3.65% (95% CI 3.25%-4.06%) and 1.38% (95% CI 0.74%-2.02%), respectively. Additionally, the total annual YLL rate increased by 4.98% (95% CI 3.92%-6.05%) and 2.68% (95% CI 1.34%-4.04%). The rates of YLL increase in persons aged 30 to 44 years (3.98%, 95% CI 0.32%-7.78%) and 45 to 59 years (4.31%, 95% CI 2.95%-5.69%) were followed by the increase in persons aged 80 years and older (10.53%, 95% CI 9.45%-11.62%) for deaths associated with DM. The annual CMR attributable to demographic factors increased by 41.9% (95% CI 17.73%-71.04%) and 36.72% (95% CI 16.69%-60.2%) for deaths associated with and due to DM, respectively. Hypertension, cerebrovascular disease, and ischemic heart disease were the top 3 comorbidities.

Conclusions: Aging and multimorbidity played essential roles in changing the burden of DM in an urbanizing and transitioning region. There is an increasing disease burden among young and middle-aged people, emphasizing the need for greater attention to these groups. Health management is an emerging method that holds important implications for alleviating the future burden of DM.

Citing Articles

All-Cause and Cause-Specific Burden of Asthma in a Transitioning City in China: Population Study.

Cheng X, Wu X, Ye W, Chen Y, Fu P, Jia W JMIR Public Health Surveill. 2024; 10():e44845.

PMID: 39621867 PMC: 11611785. DOI: 10.2196/44845.

Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder.

Azhar Ud Din M, Wan A, Chu Y, Zhou J, Yan Y, Xu Z Front Med (Lausanne). 2024; 11:1406547.

PMID: 39139783 PMC: 11319305. DOI: 10.3389/fmed.2024.1406547.

References

Kirkman M, Jones Briscoe V, Clark N, Florez H, Haas L, Halter J . Diabetes in older adults. Diabetes Care. 2012; 35(12):2650-64. PMC: 3507610. DOI: 10.2337/dc12-1801. View

Suh S, Kim K . Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment. Diabetes Metab J. 2020; 43(6):733-743. PMC: 6943263. DOI: 10.4093/dmj.2019.0177. View

Harding J, Shaw J, Peeters A, Davidson S, Magliano D . Age-Specific Trends From 2000-2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People. Diabetes Care. 2016; 39(6):1018-26. DOI: 10.2337/dc15-2308. View

Magliano D, Sacre J, Harding J, Gregg E, Zimmet P, Shaw J . Young-onset type 2 diabetes mellitus - implications for morbidity and mortality. Nat Rev Endocrinol. 2020; 16(6):321-331. DOI: 10.1038/s41574-020-0334-z. View

. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1160-1203. PMC: 7566045. DOI: 10.1016/S0140-6736(20)30977-6. View

Barone B, Yeh H, Snyder C, Peairs K, Stein K, Derr R . Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008; 300(23):2754-64. PMC: 3093051. DOI: 10.1001/jama.2008.824. View

Morley J, Abbatecola A, Woo J . Management of Comorbidities in Older Persons With Type 2 Diabetes. J Am Med Dir Assoc. 2017; 18(8):639-645. DOI: 10.1016/j.jamda.2017.05.006. View

Yang J, Yu D, Wen W, Saito E, Rahman S, Shu X . Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants. JAMA Netw Open. 2019; 2(4):e192696. PMC: 6481439. DOI: 10.1001/jamanetworkopen.2019.2696. View

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

10.

Yeung R, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon K . Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014; 2(12):935-43. DOI: 10.1016/S2213-8587(14)70137-8. View

11.

Popkin B, Adair L, Ng S . Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012; 70(1):3-21. PMC: 3257829. DOI: 10.1111/j.1753-4887.2011.00456.x. View

12.

Cole J, Florez J . Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020; 16(7):377-390. PMC: 9639302. DOI: 10.1038/s41581-020-0278-5. View

13.

Wang F, Wang W, Yin P, Liu Y, Liu J, Wang L . Mortality and Years of Life Lost in Diabetes Mellitus and Its Subcategories in China and Its Provinces, 2005-2020. J Diabetes Res. 2022; 2022:1609267. PMC: 9054436. DOI: 10.1155/2022/1609267. View

14.

Vranic M, Berger M . Exercise and diabetes mellitus. Diabetes. 1979; 28(2):147-63. DOI: 10.2337/diab.28.2.147. View

15.

Magkos F, Hjorth M, Astrup A . Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020; 16(10):545-555. DOI: 10.1038/s41574-020-0381-5. View

16.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

17.

Safar M, Gnakamene J, Bahous S, Yannoutsos A, Thomas F . Longitudinal Study of Hypertensive Subjects With Type 2 Diabetes Mellitus: Overall and Cardiovascular Risk. Hypertension. 2017; 69(6):1029-1035. DOI: 10.1161/HYPERTENSIONAHA.116.08962. View

18.

Jia G, Whaley-Connell A, Sowers J . Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2017; 61(1):21-28. PMC: 5720913. DOI: 10.1007/s00125-017-4390-4. View

19.

Wu H, Lau E, Ma R, Kong A, Wild S, Goggins W . Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study. Diabetologia. 2020; 63(4):757-766. DOI: 10.1007/s00125-019-05074-7. View

20.

Lind M, Garcia-Rodriguez L, Booth G, Cea-Soriano L, Shah B, Ekeroth G . Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia. 2013; 56(12):2601-8. DOI: 10.1007/s00125-013-3063-1. View